Vertex (VERX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity was originally published by The Motley Fool ...

Sigma Planning Corp trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 8.7% during the third quarter, according to its most recent disclosure with the ...

Vertex (VERX – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Chris Quintero from ...

Return on Assets (ROA): Zeta Global Holdings's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -4.95%, the company may face hurdles in ...

We expect investors to focus on the launch plans of Arcturus Therapeutics Holdings Inc.’s ARCT self-amplifying mRNA (sa-mRNA) ...

Palantir, Microchip Technology, and Arm Holdings are among the technology firms reporting this week, while pharmaceutical ...

Pinnacle Associates Ltd. reduced its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 44.4% in the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

“National GRIP will deepen partnerships with deeptech venture capitalists and venture builders, such as current NUS Grip 2.0 partners Legend Capital, SOSV Investments, and Vertex Holdings, by ...